NCT07293910 2026-02-13
Vonoprazan vs Proton Pump Inhibitor With Vitamin D or Probiotics Based Triple Therapy for Eradication of Helicobacter Pylori Infection
Tanta University
Phase 2 Recruiting
Clinical Trials
37 trialsNCT06510010 2026-01-26
Perioperative Oxaliplatin With S-1 Combined H. Pylori Eradication in the Management of Locally Advanced Gastric Cancer
Sixth Affiliated Hospital, Sun Yat-sen University
Phase 2 Recruiting
NCT07211880 2025-10-08
Helicobacter Pylori Infection and Gastric Disease in Bhutan: First Community-Wide, Population-Based Study
Zero Helicobacter IGAN Network
Phase NA Completed
NCT04302324 2025-10-01
A Phase II Study of Daratumumab, Clarithromycin, Pomalidomide And Dexamethasone (D-ClaPd) In Multiple Myeloma Patients Previously Exposed to Daratumumab
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT01745588 2025-09-11
Autologous Stem Cell Transplant With Pomalidomide (CC-4047®) Maintenance Versus Continuous Clarithromycin/ Pomalidomide / Dexamethasone Salvage Therapy in Relapsed or Refractory Multiple Myeloma
Memorial Sloan Kettering Cancer Center
Phase 2 Completed
NCT01559935 2025-09-08
CarBiRD
Weill Medical College of Cornell University
Phase 2 Active not recruiting
NCT07144657 2025-08-27
GastricMALToma
National Taiwan University Hospital
Phase 2 Not yet recruiting
NCT07068607 2025-08-14
Efficacy Comparison of Vonoprazan Combined With Different Antibiotics in Dual Therapy for Helicobacter Pylori Eradication: A Prospective, Randomized Controlled Clinical Trial
Xijing Hospital of Digestive Diseases
Phase 4 Recruiting
NCT05742568 2025-07-03
Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT03031483 2025-01-30
Clarithromycin + Lenalidomide Combination: a Full Oral Treatment for Patients With Relapsed/Refractory Extranodal Marginal Zone Lymphoma
International Extranodal Lymphoma Study Group (IELSG)
Phase 2 Completed
NCT06207786 2024-11-25
Nasal Iodine Swab Versus Oral Antibiotic to Prevent Surgical Site Infection After Undergoing Mohs Micrographic Surgery
Mayo Clinic
Phase NA Withdrawn
NCT02387203 2024-11-19
Antibiotic Treatment and Long-term Outcomes of Patients With Pseudomyxoma Peritonei of Appendiceal Origin
Mercy Medical Center
Phase 2 Active not recruiting
NCT02542657 2024-09-19
Ixazomib with Pomalidomide, Clarithromycin and Dexamethasone in Treating Patients with Multiple Myeloma
University of California, Davis
Phase 1/2 Active not recruiting
NCT04843579 2023-10-25
ClaSPd
Weill Medical College of Cornell University
Phase 2 Terminated
NCT02516696 2023-06-05
BiRd vs Rd
Weill Medical College of Cornell University
Phase 3 Terminated
NCT04697186 2023-01-31
Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy
Xijing Hospital of Digestive Diseases
Phase 4 Completed
NCT01516606 2022-08-12
HD-K
IRCCS San Raffaele
Phase 2 Completed
NCT02575144 2022-02-01
GEM-CLARIDEX
PETHEMA Foundation
Phase 3 Unknown
NCT04287660 2021-10-25
Study of BiRd Regimen Combined With BCMA CAR T-cell Therapy in Newly Diagnosed Multiple Myeloma (MM) Patients
The First Affiliated Hospital of Soochow University
Phase 3 Unknown
NCT00151203 2021-05-27
Phase II Study of Biaxin, Revlimid, and Dexamethasone for Untreated Multiple Myeloma
Weill Medical College of Cornell University
Phase 2 Completed
NCT00538733 2021-05-24
T-BiRD
Weill Medical College of Cornell University
Phase 2 Completed
NCT03043989 2020-02-17
Cohorts of Docetaxel or Cabazitaxel in Combination With the Potent CYP3A4 Inhibitor, Clarithromycin
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 1 Terminated
NCT00445692 2019-11-13
Lenalidomide, Dexamethasone, and Clarithromycin in Treating Patients Who Have Undergone Stem Cell Transplant for Multiple Myeloma
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT01159574 2019-06-11
Study of Decadron, Biaxin, and Pomalidomide in Relapsed/Refractory Myeloma
Weill Medical College of Cornell University
Phase 2 Completed
NCT01279252 2019-01-25
CLEAR
King's College Hospital NHS Trust
Phase 2 Completed
NCT01374217 2018-12-10
Administration of Tadalafil in Conjunction With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Terminated
NCT00002682 2018-10-24
Antibiotic Therapy and Antacids in Patients With Malt Lymphoma of the Stomach
M.D. Anderson Cancer Center
Phase 2 Completed
NCT02986451 2018-08-14
Clarithromycin,Lenalidomide and Dexamethasone for Relapsed/Refractory Myeloma
Sun Yat-sen University
Phase 2 Withdrawn
NCT02852083 2018-01-18
ModuLung
University Hospital Regensburg
Phase 2 Unknown
NCT02248428 2017-09-06
CTd
Jinling Hospital, China
Phase 3 Unknown
NCT00182663 2017-06-26
Thalidomide, Dexamethasone, and Clarithromycin in Treating Patients With Multiple Myeloma Previously Treated With Transplant
Fred Hutchinson Cancer Center
Phase 2 Completed
NCT02573935 2016-09-20
CLAIM
Aalborg University Hospital
Phase 2 Terminated
NCT02416570 2016-09-16
Is Clarithromycin a Potential Treatment for Cachexia in People With Lung Cancer?
University of Nottingham
Phase 2 Terminated
NCT00201422 2016-03-28
Eradication of Helicobacter Pylori in the Management of Stage IE & IIE-1 Primary Low-grade B Cell Lymphoma of MALToma
National Health Research Institutes, Taiwan
Phase NA Completed
NCT02388581 2016-03-25
First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCL
National Health Research Institutes, Taiwan
Phase 2 Unknown
NCT02624440 2015-12-08
SUTRICA
Aalborg University Hospital
Phase 2 Unknown
NCT00154440 2007-03-26
Helicobacter - Lymphoma - Radiation Part I: Eradication, Part II: Radiation
Technische Universität Dresden
Phase 3 Unknown